The AI Inflection Point: 2026 State of Clinical Trial Technology Report

The clinical trial industry has reached an AI inflection point.

Florence’s 2026 State of Clinical Trial Technology Report is here. We surveyed 400+ clinical trial professionals, including 326 site leaders, 46 sponsor executives, and 44 CRO decision-makers. Together, their perspectives reveal a core truth: AI is widening the digital divide, and we need to act fast. 

This year’s report goes beyond trends. It defines the strategic imperatives shaping the future of site operations, sponsor oversight, and CRO execution.

Inside the report, you’ll uncover:

• The AI Inflection Point
  How AI is widening the chasm for organizations with modern digital infrastructure, and exposing those still dependent on paper, email, and fragmented systems.
• The Next Wave of Site-Facing Technology
  What’s coming next in feasibility, recruitment, participant payments, lab management, contracts, image management, and what a leading site technology stack looks like.
• Where AI Experimentation Is Taking Off
  Which AI use cases are most prevalent today and where gaps in digitization, data quality, governance, and system connectivity must be addressed to scale responsibly.
• The Power of Flexible Digital Mandates
  Why rigid, top-down mandates fail, and how flexible approaches can unlock transformation for 56% of clinical trial documentation that still originate on paper.
• The Move Towards Persistent Intelligence
  Why sponsors need to break the transactional study-by-study model and invest in longitudinal datasets that enable smarter site feasibility and selection.

Download the full 2026 State of the Industry Report here.